Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.

Iihara H, Shimokawa M, Bando H, Niwa Y, Mizuno Y, Kawaguchi Y, Kitahora M, Murakami A, Kawai M, Ishida K, Takeuchi M, Ishihara K, Iyoda T, Nakada T, Ogiso A, Kojima Y, Kumagai F, Sawa A, Mori R, Higuchi K, Furuta T, Kamei Y, Tsuchiya M, Terasaki A, Yamamoto S, Kitazawa M, Okazaki M, Suzuki A, Futamura M

Open source

DOI: 10.7150/jca.87169
Published: 2023
Container: Journal of Cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7150/jca.87169,
  title = {Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.},
  author = {Iihara H and Shimokawa M and Bando H and Niwa Y and Mizuno Y and Kawaguchi Y and Kitahora M and Murakami A and Kawai M and Ishida K and Takeuchi M and Ishihara K and Iyoda T and Nakada T and Ogiso A and Kojima Y and Kumagai F and Sawa A and Mori R and Higuchi K and Furuta T and Kamei Y and Tsuchiya M and Terasaki A and Yamamoto S and Kitazawa M and Okazaki M and Suzuki A and Futamura M},
  year = {2023},
  journal = {Journal of Cancer},
  doi = {10.7150/jca.87169},
  url = {https://doi.org/10.7150/jca.87169}
}

RIS

TY  - JOUR
TI  - Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
AU  - Iihara H
AU  - Shimokawa M
AU  - Bando H
AU  - Niwa Y
AU  - Mizuno Y
AU  - Kawaguchi Y
AU  - Kitahora M
AU  - Murakami A
AU  - Kawai M
AU  - Ishida K
AU  - Takeuchi M
AU  - Ishihara K
AU  - Iyoda T
AU  - Nakada T
AU  - Ogiso A
AU  - Kojima Y
AU  - Kumagai F
AU  - Sawa A
AU  - Mori R
AU  - Higuchi K
AU  - Furuta T
AU  - Kamei Y
AU  - Tsuchiya M
AU  - Terasaki A
AU  - Yamamoto S
AU  - Kitazawa M
AU  - Okazaki M
AU  - Suzuki A
AU  - Futamura M
PY  - 2023
JO  - Journal of Cancer
DO  - 10.7150/jca.87169
UR  - https://doi.org/10.7150/jca.87169
ER  -

APA

H, I., M, S., H, B., Y, N., Y, M., Y, K., M, K., A, M., M, K., K, I., M, T., K, I., T, I., T, N., A, O., Y, K., F, K., A, S., R, M., K, H., T, F., Y, K., M, T., A, T., S, Y., M, K., M, O., A, S., & M, F. (2023). Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.. Journal of Cancer. https://doi.org/10.7150/jca.87169

Source records

pubmed · retrieved 2026-09-27T13:33:18.880Z